Demographic characteristics of patients using a fully integrated psychosocial support service for cancer patients
- PMID: 20003474
- PMCID: PMC2799437
- DOI: 10.1186/1756-0500-2-253
Demographic characteristics of patients using a fully integrated psychosocial support service for cancer patients
Abstract
Background: Psychosocial support services are an important component of modern cancer treatment. A major challenge for all psychosocial services is the achievement of equity of use. Previous studies in the UK have found that women of higher socio-economic status with breast cancer were over-represented amongst those accessing support services. People with other cancer diagnoses, those from socio-economically deprived areas, and men, were under-represented.
Findings: The Oncology Health Service, Kingston Upon Hull, UK, delivers fully integrated psychosocial support and interventions. To assess equity of access in this service, a cross-sectional study of all patients with cancer accessing the service during a 5 day period was carried out. One hundred and forty-five patients attended. Forty four percent were male, and the types of cancer were broadly in the proportions expected on the basis of population prevalence (breast cancer 22%, colorectal cancer 21%, lung cancer 16%). Sixty six percent came from the three most deprived quintiles of the Townsend deprivation Index.
Conclusions: The fully integrated Oncology Health Service in Hull is accessed by a more diverse range of patients than previously reported for other services, and is an example of a model of service by which socially equitable use of psychosocial support in the National Health Service might be achieved.
References
-
- Anderson J, Walker LG. In: The Psychoimmunology of Cancer. 2. Lewis CE, O'Brien R, Barraclough J, editor. Chapter 7. Oxford University Press, Oxford; 2002. Psychological factors and cancer progression: involvement of behavioural pathways. ISBN: 0192630601.
-
- Hopwood P, Watkins J, Ellis P, Smith I. Clinical Interpretation of quality of life outcomes: an investigation of data from the randomised trial of gemcitabine plus paclitaxel compared with paclitaxel alone for advanced breast cancer. The Breast J. 2008;14(3):228–235. doi: 10.1111/j.1524-4741.2008.00567.x. - DOI - PubMed
-
- Walker LG, Green VL, Greenman J, Walker AA, Sharp DM. In: Human Psychoneuroimmunology (PNI) Irwin M, Vedhara V, editor. Oxford University Press, Oxford; 2005. PNI and chronic malignant disease: Cancer.
LinkOut - more resources
Full Text Sources
